Xenon Pharmaceuticals Inc

(NASDAQ:XENE)

Latest On Xenon Pharmaceuticals Inc (XENE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsXenon Pharmaceuticals: Navigating The Neural Network Of Epilepsy And DepressionN/A
2023-05-13 22:20 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 20:01 ESTNewsXenon Pharma GAAP EPS of -$0.63 beats by $0.01N/A
2023-05-09 05:53 ESTNewsXenon Pharma Q1 2023 Earnings PreviewN/A
2023-03-15 18:51 ESTNewsXenon May Have A Surprise In Store For Major Depressive DisorderN/A
2023-03-02 08:45 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 18:23 ESTNewsXenon Pharma GAAP EPS of -$0.57 beats by $0.02N/A
2023-03-01 03:05 ESTNewsXenon Pharma Q4 2022 Earnings PreviewN/A
2023-02-08 14:29 ESTNewsXenon Pharmaceuticals: De-Risked Late-Stage Neurology Biotech, BuyN/A
2022-12-23 16:03 ESTNewsXenon Pharmaceuticals: Momentum Still Accelerating, Rate Buy (Technical Analysis)N/A
2022-11-28 20:23 ESTNewsXenon initiated Overweight at Wells Fargo on prospects in depressionN/A
2022-11-08 21:25 ESTNewsXenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89MN/A
2022-11-08 21:24 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q3 2022 Earnings Call TranscriptN/A
2022-10-19 16:36 ESTNewsXenon started at outperform at Raymond James on experimental epilepsy drugN/A
2022-09-06 17:12 ESTNewsPutting Xenon Pharmaceuticals Back In The SpotlightN/A
2022-08-29 20:33 ESTNewsXenon initiated with Buy at BofA citing potential of anti-seizure drugN/A
2022-08-11 01:42 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 07:40 ESTNewsXenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71MN/A
2022-08-09 11:57 ESTNewsXenon Pharma Q2 2022 Earnings PreviewN/A
2022-07-22 07:20 ESTNewsXenon added to JP Morgan’s analyst focus list citing lead assetN/A
2022-06-23 22:26 ESTNewsXenon Pharmaceuticals slides on pricing $250M equity offeringN/A
2022-06-23 22:26 ESTNewsHot Stocks: OXY rises as Buffett adds shares, SNOW pops on upgrade, KBH also gains and XENE declinesN/A
2022-06-23 03:58 ESTNewsXenon slips 11% on public offering of common stockN/A
2022-05-11 12:48 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 17:11 ESTNewsXenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03MN/A
2022-05-09 19:04 ESTNewsXenon Pharmaceuticals Q1 Earnings PreviewN/A
2022-03-02 08:46 ESTNewsXenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13MN/A
2022-03-02 08:46 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-19 20:02 ESTNewsXenon draws buyout speculation after Zogenix dealN/A
2022-01-12 13:22 ESTNewsXenon passes regulatory mark to receive $15M from Neurocrine BiosciencesN/A
2021-12-14 04:59 ESTNewsSizing Up Xenon PharmaceuticalsN/A
2021-12-11 00:58 ESTNewsXenon Pharmaceuticals (XENE) Presents At AES 2021 SymposiumN/A
2021-12-08 15:45 ESTNewsXenon Pharmaceuticals jumps 5% on insider buying worth $100KN/A
2021-12-07 00:52 ESTNewsXenon Pharmaceuticals (XENE) Investor Presentation - SlideshowN/A
2021-12-03 23:16 ESTNewsXenon Pharma presents additional positive data from Phase 2b X-TOLE trial at AES 2021N/A
2021-11-11 15:47 ESTNewsXenon Pharmaceuticals' (XENE) CEO Ian Mortimer on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsXenon Pharma EPS beats by $0.01, misses on revenueN/A
2021-11-09 19:56 ESTNewsXenon Pharma Q3 2021 Earnings PreviewN/A
2021-10-06 21:06 ESTNewsXenon Pharma secures $300M capital raise via equity offeringN/A
2021-10-05 18:52 ESTNewsXenon Pharmaceuticals rises ~4% amid launch of $250M stock offeringN/A
2021-10-04 16:06 ESTNewsXenon Pharma stock jumps 80% on positive XEN1101 data in mid-stage focal epilepsy studyN/A
2021-09-08 18:36 ESTNewsXenon Pharmaceuticals gets $10M milestone payment from Neurocrine collaborationN/A
2021-08-23 17:59 ESTNewsNew medical chief at Xenon PharmaN/A
2021-08-12 06:35 ESTNewsXenon Pharma EPS misses by $0.03, misses on revenueN/A
2021-08-12 06:34 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 09:06 ESTNewsXenon completes patient randomization in mid-stage XEN1101 epilepsy trialN/A
2021-03-10 02:08 ESTNewsXenon Pharmaceuticals readies stock offeringN/A
2021-03-10 02:08 ESTNewsXenon Pharma secures $100M via equity raiseN/A
2021-03-09 06:58 ESTNewsXenon strikes research deal for major depressive disorder treatment XEN1101N/A
2021-03-04 12:48 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $25.29.Buy

About Xenon Pharmaceuticals Inc (XENE):

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

XENE Quotes by TradingView

See Advanced Chart

General

  • Name Xenon Pharmaceuticals Inc
  • Symbol XENE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 123
  • Fiscal Year EndDecember
  • IPO Date2014-11-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.xenon-pharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 20.81
  • Price/Book (Most Recent Quarter) 4.24
  • Enterprise Value Revenue 16.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.45
  • Profit Margin -90%
  • Operating Margin -97%
  • Return on Assets -12%
  • Return on Equity -22%
  • Revenue 32.17 million
  • Earnings Per Share -$1.72
  • Revenue Per Share $0.93
  • Gross Profit -18357000
  • Quarterly Earnings Growth 54.7%
View More

Highlights

  • Market Capitalization 658.17 million
  • EBITDA -44423000
  • PE Ratio -18.63
  • PEG Ratio -0.06
  • Analyst Target Price $25.29
  • Book Value Per Share $4.67
View More

Share Statistics

  • Shares Outstanding 35.81 million
  • Shares Float 23.33 million
  • % Held by Insiders 658%
  • % Held by Institutions 81.3%
  • Shares Short 943938
  • Shares Short Prior Month 977125
  • Short Ratio 5.34
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.42
  • 52 Week High $21.94
  • 52 Week Low $8.95
  • 50 Day Moving Average 17.43
  • 200 Day Moving Average 13.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Xenon Pharmaceuticals Inc (XENE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Xenon Pharmaceuticals Inc (XENE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$5.15 million-$0.34-$0.4015%
2020-09-302020-11-05$N/A-$0.25-$0.17-47.06%
2020-06-302020-08-06$N/A$-0.00-$0.2097.52%
2020-03-312020-05-21$7.08 million-$0.22-$0.3129.6%
2019-12-312020-03-09$3.33 million-$0.41$0.12-441.67%
2019-09-302019-11-05$3.5 million-$0.33-$0.4628.26%
2019-06-302019-08-06$N/A-$0.37-$0.4518.38%
2019-03-312019-05-07$N/A-$0.42-$0.37-13.51%
2018-12-312019-03-06$N/A-$0.29-$0.3619.44%
2018-09-302018-11-06$N/A-$0.63-$0.40-57.5%
2018-06-302018-08-07$N/A-$0.45-$0.498.16%
2018-03-312018-05-08$N/A-$0.46-$0.484.96%
2017-12-312018-03-07$16000-$0.45-$0.44-2.27%
2017-09-302017-11-07$264000-$0.43-$0.39-10.26%
2017-06-302017-08-03$15000-$0.41-$0.39-6.03%
2017-03-312017-05-09$16000-$0.42-$0.38-9.57%
2016-12-312017-03-08$376000-$0.32-$0.4223.21%
2016-09-302016-11-03$413000-$0.51-$0.44-15.25%
2016-06-302016-08-03$413000-$0.42-$0.5016%
2016-03-312016-05-10$601000-$0.23-$0.21-9.52%
2015-12-312016-03-08$3.23 million-$0.27-$0.26-3.85%
2015-09-302015-11-10$4.29 million-$0.27-$0.01-2600%
2015-06-302015-08-10$4.05 million$0.08-$0.15153.33%
2015-03-312015-05-12$4.01 million-$0.30$0.14-314.29%
2014-12-312015-03-12$4.88 million$2.54-$0.0125500%
2014-09-302014-12-15$13.19 million$1.69

Xenon Pharmaceuticals Inc (XENE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Xenon Pharmaceuticals Inc (XENE) Chart:

Xenon Pharmaceuticals Inc (XENE) News:

Below you will find a list of latest news for Xenon Pharmaceuticals Inc (XENE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Xenon Pharmaceuticals Inc (XENE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-1917.50CALL0 0201.03TRUE00
2025-09-192011.7CALL0 1164.21TRUE00
2025-09-1922.50CALL0 0187.33TRUE00
2025-09-19250CALL0 0174.29TRUE00
2025-09-1927.50CALL0 0139.11TRUE00
2025-09-19300CALL0 0106.16TRUE00
2025-09-1932.55.05CALL0 468.98TRUE00
2025-09-19352.95CALL0 551.65TRUE00
2025-09-1937.51CALL1 37650.7FALSE10
2025-09-19401.88CALL0 6676.31FALSE00
2025-09-1942.50.95CALL0 2191.83FALSE00
2025-09-19450.5CALL0 1051117.42FALSE00
2025-09-1947.50CALL0 0241.36FALSE00
2025-09-19500.22CALL0 57158.03FALSE00
2025-09-1917.50PUT0 0299.13FALSE00
2025-09-19200PUT0 0498.23FALSE00
2025-09-1922.50PUT0 0427.54FALSE00
2025-09-19250PUT0 0364.22FALSE00
2025-09-1927.50.34PUT0 54129.91FALSE00
2025-09-19300.23PUT0 55112.18FALSE00
2025-09-1932.51.46PUT0 3199.93FALSE00
2025-09-19352.7PUT0 173.99FALSE00
2025-09-1937.51.3PUT0 10050.84TRUE00
2025-09-19401.05PUT0 556.28TRUE00
2025-09-1942.50PUT0 078.89TRUE00
2025-09-19450PUT0 084.81TRUE00
2025-09-1947.50PUT0 0115.6TRUE00
2025-09-19500PUT0 0109.91TRUE00
2025-10-17150CALL0 0116.65TRUE00
2025-10-1717.50CALL0 0126.44TRUE00
2025-10-17200CALL0 00TRUE00
2025-10-1722.50CALL0 085.31TRUE00
2025-10-17250CALL0 079.94TRUE00
2025-10-1727.50CALL0 070.45TRUE00
2025-10-17308.5CALL0 550.84TRUE00
2025-10-1732.57.6CALL0 2956.19TRUE00
2025-10-17354.5CALL0 1445.55TRUE00
2025-10-1737.53.5CALL0 148.46FALSE00
2025-10-17401.3CALL0 3662.88FALSE00
2025-10-1742.50.75CALL0 29483.91FALSE00
2025-10-17450.7CALL0 4162.88FALSE00
2025-10-1747.50CALL0 5116.67FALSE00
2025-10-17500.35CALL0 2125.61FALSE00
2025-10-17550.6CALL0 2142.84FALSE00
2025-10-17150PUT0 0181.18FALSE00
2025-10-1717.50PUT0 0209.59FALSE00
2025-10-17200PUT0 0134.71FALSE00
2025-10-1722.50PUT0 1202.37FALSE00
2025-10-17250PUT0 1174.31FALSE00
2025-10-1727.50PUT0 0148.41FALSE00
2025-10-17300.32PUT0 42123.97FALSE00
2025-10-1732.51.15PUT0 10104.15FALSE00
2025-10-17351.1PUT0 350440.19FALSE00
2025-10-1737.50PUT0 747.15TRUE00
2025-10-17400PUT0 348.02TRUE00
2025-10-1742.50PUT0 052.43TRUE00
2025-10-17450PUT0 053.04TRUE00
2025-10-1747.50PUT0 060.93TRUE00
2025-10-17500PUT0 074.42TRUE00
2025-10-17550PUT0 072.09TRUE00
2025-12-19150CALL0 00TRUE00
2025-12-1917.50CALL0 00TRUE00
2025-12-19200CALL0 065.01TRUE00
2025-12-1922.50CALL0 2556.13TRUE00
2025-12-19257.3CALL0 5355.3TRUE00
2025-12-1927.55.7CALL0 7850.59TRUE00
2025-12-19309.07CALL0 2747.54TRUE00
2025-12-1932.57.2CALL0 746.96TRUE00
2025-12-19355.67CALL0 2543.77TRUE00
2025-12-1937.52.5CALL0 60641.96FALSE00
2025-12-19403.5CALL0 66644.26FALSE00
2025-12-1942.50.45CALL0 5546.76FALSE00
2025-12-19451.8CALL0 4277.33FALSE00
2025-12-1947.51.23CALL0 3179.93FALSE00
2025-12-19500.35CALL0 584.27FALSE00
2025-12-1952.50CALL0 187.83FALSE00
2025-12-19550CALL0 3190.71FALSE00
2025-12-19600.61CALL0 498.77FALSE00
2025-12-19650.5CALL0 3105.35FALSE00
2025-12-19150.3PUT0 2109.94FALSE00
2025-12-1917.50PUT0 3110.14FALSE00
2025-12-19200PUT0 4141.83FALSE00
2025-12-1922.50PUT0 2125.51FALSE00
2025-12-19250PUT0 2109.41FALSE00
2025-12-1927.50.87PUT0 1096.33FALSE00
2025-12-19300.8PUT0 2385.29FALSE00
2025-12-1932.51.4PUT0 677.76FALSE00
2025-12-19355.9PUT0 146.03FALSE00
2025-12-1937.50PUT0 1244.55TRUE00
2025-12-19407.5PUT0 1942.69TRUE00
2025-12-1942.50PUT0 147.58TRUE00
2025-12-19450PUT0 447.1TRUE00
2025-12-1947.50PUT0 046.11TRUE00
2025-12-19500PUT0 048.91TRUE00
2025-12-1952.50PUT0 048.63TRUE00
2025-12-19550PUT0 056.76TRUE00
2025-12-19600PUT0 060.29TRUE00
2025-12-19650PUT0 065.36TRUE00
2026-01-16150CALL0 00TRUE00
2026-01-1617.50CALL0 070.68TRUE00
2026-01-16200CALL0 074.94TRUE00
2026-01-1622.50CALL0 072.41TRUE00
2026-01-16258.8CALL0 8068.7TRUE00
2026-01-1627.50CALL0 068.02TRUE00
2026-01-163012.1CALL0 1666.25TRUE00
2026-01-1632.510.01CALL0 167.76TRUE00
2026-01-16357.5CALL0 1666.68TRUE00
2026-01-1637.56.8CALL0 266.58FALSE00
2026-01-16404.81CALL1 965.29FALSE4.810
2026-01-1642.54.9CALL0 166.38FALSE00
2026-01-16451.75CALL0 168.43FALSE00
2026-01-1647.51.5CALL0 068.66FALSE00
2026-01-16503.5CALL0 270.24FALSE00
2026-01-16552.7CALL0 172.87FALSE00
2026-01-16150.5PUT0 1116.74FALSE00
2026-01-1617.50PUT0 0149.88FALSE00
2026-01-16200.75PUT0 2132.79FALSE00
2026-01-1622.50.7PUT0 1119.58FALSE00
2026-01-16250PUT0 0109.02FALSE00
2026-01-1627.51.9PUT0 169.37FALSE00
2026-01-16302.55PUT0 267.06FALSE00
2026-01-1632.53.7PUT0 166.15FALSE00
2026-01-16350PUT0 066.43FALSE00
2026-01-1637.55PUT0 162.53TRUE00
2026-01-16400PUT0 067.72TRUE00
2026-01-1642.50PUT0 063.06TRUE00
2026-01-16450PUT0 069.65TRUE00
2026-01-1647.50PUT0 070.36TRUE00
2026-01-16500PUT0 069.89TRUE00
2026-01-16550PUT0 069.62TRUE00
2026-04-17200CALL0 082.85TRUE00
2026-04-1722.50CALL0 085.6TRUE00
2026-04-172516CALL0 184.72TRUE00
2026-04-1727.50CALL0 085.39TRUE00
2026-04-173014.5CALL0 1086.11TRUE00
2026-04-1732.50CALL0 087.01TRUE00
2026-04-173510.1CALL0 186.24TRUE00
2026-04-1737.50CALL0 085.51FALSE00
2026-04-17408.11CALL1 177.82FALSE8.110
2026-04-1742.57.03CALL0 484FALSE00
2026-04-17456.7CALL0 485.93FALSE00
2026-04-1747.56.6CALL0 189.86FALSE00
2026-04-17506.19CALL0 283.65FALSE00
2026-04-17556CALL0 283.28FALSE00
2026-04-17201.55PUT0 2121.39FALSE00
2026-04-1722.52.15PUT0 386.21FALSE00
2026-04-17252.9PUT0 186.61FALSE00
2026-04-1727.54.9PUT0 188.23FALSE00
2026-04-17300PUT0 091.67FALSE00
2026-04-1732.57.2PUT0 182.9FALSE00
2026-04-17350PUT0 089.04FALSE00
2026-04-1737.50PUT0 087.19TRUE00
2026-04-17409.5PUT0 686.41TRUE00
2026-04-1742.50PUT0 085.79TRUE00
2026-04-174512.8PUT0 386.69TRUE00
2026-04-1747.50PUT0 086.53TRUE00
2026-04-17500PUT0 084.92TRUE00
2026-04-17550PUT0 085.5TRUE00

Latest XENE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$27.26
Jun 13, 2022 7:59 PM EST89$27.26
Jun 13, 2022 7:59 PM EST5$27.24
Jun 13, 2022 7:59 PM EST3$27.24
Jun 13, 2022 7:59 PM EST26$27.24

Xenon Pharmaceuticals Inc (XENE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000019012321/0000000000-19-012321-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000020005143/0000000000-20-005143-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000085874419000023/0000858744-19-000023-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319007264/0000899243-19-007264-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2018-07-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266418002713/0000902664-18-002713-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419000946/0000902664-19-000946-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419001016/0000902664-19-001016-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266420000959/0000902664-20-000959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189519000466/0000921895-19-000466-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520000548/0000921895-20-000548-index.htm
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004459/0001171843-18-004459-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004460/0001171843-18-004460-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004461/0001171843-18-004461-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008556/0001171843-18-008556-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050127/0001209191-19-050127-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050129/0001209191-19-050129-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050131/0001209191-19-050131-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050133/0001209191-19-050133-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050143/0001209191-19-050143-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050146/0001209191-19-050146-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050164/0001209191-19-050164-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050166/0001209191-19-050166-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050169/0001209191-19-050169-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050172/0001209191-19-050172-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2020-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003271/0001209191-20-003271-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003273/0001209191-20-003273-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018941/0001209191-20-018941-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018951/0001209191-20-018951-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018958/0001209191-20-018958-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018963/0001209191-20-018963-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018969/0001209191-20-018969-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033593/0001209191-20-033593-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033596/0001209191-20-033596-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033605/0001209191-20-033605-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033627/0001209191-20-033627-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033639/0001209191-20-033639-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033643/0001209191-20-033643-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033653/0001209191-20-033653-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-08-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046970/0001209191-20-046970-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046974/0001209191-20-046974-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120048095/0001209191-20-048095-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-11-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057205/0001209191-20-057205-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057208/0001209191-20-057208-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000121390020003603/0001213900-20-003603-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000162/0001422849-18-000162-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000178/0001422849-18-000178-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018015497/0001564590-18-015497-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016554/0001564590-18-016554-index.htm
2018-07-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018016768/0001564590-18-016768-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016771/0001564590-18-016771-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020000/0001564590-18-020000-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020005/0001564590-18-020005-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018020018/0001564590-18-020018-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022422/0001564590-18-022422-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022703/0001564590-18-022703-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022911/0001564590-18-022911-index.htm
2018-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023027/0001564590-18-023027-index.htm
2018-09-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023031/0001564590-18-023031-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023099/0001564590-18-023099-index.htm
2018-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023102/0001564590-18-023102-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018027409/0001564590-18-027409-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018027475/0001564590-18-027475-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006512/0001564590-19-006512-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459019006514/0001564590-19-006514-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006522/0001564590-19-006522-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019007593/0001564590-19-007593-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019009156/0001564590-19-009156-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019013752/0001564590-19-013752-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019016573/0001564590-19-016573-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019016580/0001564590-19-016580-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019021713/0001564590-19-021713-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019029412/0001564590-19-029412-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019029418/0001564590-19-029418-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459019029440/0001564590-19-029440-index.htm
2019-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459019031813/0001564590-19-031813-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034466/0001564590-19-034466-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034720/0001564590-19-034720-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040445/0001564590-19-040445-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040449/0001564590-19-040449-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040458/0001564590-19-040458-index.htm
2019-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040484/0001564590-19-040484-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019044971/0001564590-19-044971-index.htm
2019-12-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1582313/000156459019045741/0001564590-19-045741-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000685/0001564590-20-000685-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000901/0001564590-20-000901-index.htm
2020-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001642/0001564590-20-001642-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020001789/0001564590-20-001789-index.htm
2020-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001790/0001564590-20-001790-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009357/0001564590-20-009357-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459020009385/0001564590-20-009385-index.htm
2020-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009391/0001564590-20-009391-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010133/0001564590-20-010133-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010811/0001564590-20-010811-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020019198/0001564590-20-019198-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020021912/0001564590-20-021912-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020026545/0001564590-20-026545-index.htm
2020-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026574/0001564590-20-026574-index.htm
2020-05-2210-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026739/0001564590-20-026739-index.htm
2020-05-2610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026807/0001564590-20-026807-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028137/0001564590-20-028137-index.htm
2020-06-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028139/0001564590-20-028139-index.htm
2020-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459020028142/0001564590-20-028142-index.htm
2020-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028884/0001564590-20-028884-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037751/0001564590-20-037751-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037862/0001564590-20-037862-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037867/0001564590-20-037867-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037893/0001564590-20-037893-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020040375/0001564590-20-040375-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020051310/0001564590-20-051310-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020051443/0001564590-20-051443-index.htm
2018-07-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577418006468/0001615774-18-006468-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577419002513/0001615774-19-002513-index.htm
2019-08-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999519001895/9999999995-19-001895-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999520001418/9999999995-20-001418-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718007811/9999999997-18-007811-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718009592/9999999997-18-009592-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006777/9999999997-19-006777-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006778/9999999997-19-006778-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720000547/9999999997-20-000547-index.htm
2020-02-27SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720001048/9999999997-20-001048-index.htm
2020-09-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999720004559/9999999997-20-004559-index.htm

Xenon Pharmaceuticals Inc (XENE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xenon Pharmaceuticals Inc (XENE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 658%
Institutional Ownership: 8130%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-20FRANK A HOLLERDirectorSell5,206.009.3948,884.34118,955.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12SHERRINGTON ROBINEVP, Strategy & InnovationBuy6,172.003.0718,948.0412,064.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.7011,418.20122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-05-29FRANK A HOLLERDirectorBuy3,086.003.5610,986.16122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2019-09-19FRANK A HOLLERDirectorSell7,600.009.2770,452.00124,161.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.079,474.02124,193.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-18FRANK A HOLLERDirectorSell4,368.009.2840,535.04131,761.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-17FRANK A HOLLERDirectorSell5,069.009.3247,243.08136,129.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-12FRANK A HOLLERDirectorBuy25,720.003.0077,160.00148,979.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-06-01SHERRINGTON ROBINEVP, Strategy & InnovationBuy8,230.003.5629,298.8018,426.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2018-12-14GARY PATOUDirectorBuy2,057.003.076,314.9919,459.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-06-14GARY PATOUDirectorBuy8,230.003.7030,451.0020,258.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2019-12-04GARY PATOUDirectorBuy2,057.003.567,322.9221,516.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2020-10-28GARY PATOUDirectorBuy2,057.003.767,734.3223,573.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-06-01SIMON N. PIMSTONECEOSell3,000.0014.4343,290.00255,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-20SIMON N. PIMSTONECEOSell10,395.009.5198,856.45258,122.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2020-05-29SIMON N. PIMSTONECEOSell5,000.0013.9969,950.00258,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy9,259.003.0728,425.13262,633.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy36,008.003.70133,229.60264,143.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2020-05-26SIMON N. PIMSTONECEOBuy6,172.003.5621,972.32264,294.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy12,345.003.3841,726.10272,209.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-03-19Michael R HaydenDirectorBuy20,576.003.3869,546.8850,924.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2018-06-21MOHAMMAD AZABDirectorBuy10,288.003.7038,065.6054,498.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2019-09-13MOHAMMAD AZABDirectorSell23.009.31214.1857,561.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2018-12-06MOHAMMAD AZABDirectorBuy3,086.003.079,474.0257,584.00https://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.7019,032.8060,311.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-12-16MOHAMMAD AZABDirectorBuy3,086.003.5610,986.1660,647.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy2,057.003.667,528.6262,368.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-05-21MICHAEL M TARNOWDirectorBuy2,057.003.216,602.9764,569.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy2,057.003.517,220.0766,626.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.0715,792.0867,512.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy5,144.003.5618,312.6469,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2020-06-09MICHAEL M TARNOWDirectorBuy5,144.003.5218,106.8869,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4474,857.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4480,001.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2018-12-11CHARLES J. COHENVP, BiologyBuy4,115.003.0712,633.058,194.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm